September 2025
1. CHOW JKL, Vest AR, DeNofrio D, Snydman DR, et al
   Tolerability and Clinical Efficacy of Letermovir for Primary Cytomegalovirus Prophylaxis After Heart Transplantation.
   J Heart Lung Transplant. 2025 Sep 11:S1053-2498(25)02257.
   

   >> Share

   
   November 2024
2. BLUMBERG EA, Witzke O, Mbbs MH, Ison MG, et al
   Maribavir for refractory cytomegalovirus infection (with or without resistance) in solid organ transplant recipients: subgroup analysis of the phase 3 randomized SOLSTICE study.
   J Heart Lung Transplant. 2024 Nov 27:S1053-2498(24)01971.
   

   >> Share

   
   July 2024
3. KUHNER LM, Berger SM, Djinovic M, Furlano PL, et al
   Immunomodulatory soluble HLA-G and HLA-E are associated with rapidly deteriorating CLAD and HCMV viremia after lung transplantation.
   J Heart Lung Transplant. 2024 Jul 25:S1053-2498(24)01747.
   

   >> Share

   
   December 2023
4. BELGA S, Hussain S, Avery RK, Nauroz Z, et al
   Impact of recipient age on mortality among CMV-seronegative lung transplant recipients with CMV-seropositive donors.
   J Heart Lung Transplant. 2023 Dec 5:S1053-2498(23)02143.
   

   >> Share

   
   October 2023
5. GONDI KT, Kaul DR, Gregg KS, Golbus JR, et al
   Cytomegalovirus Infection is Associated with Impaired Myocardial Flow Reserve After Heart Transplantation.
   J Heart Lung Transplant. 2023 Oct 7:S1053-2498(23)02063.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share